芬兰子宫内膜去除术后长期随访:癌症风险与后续子宫切除术
这项回顾性队列研究纳入芬兰1997-2014年间30-49岁接受子宫内膜去除术的5,484名女性,随访39,892人年,发现子宫内膜癌和乳腺癌风险未升高,但后续子宫切除术风险较对照组增加近四倍(调整HR 3.63,95%CI 3.32-3.96)。
要点
- 子宫内膜去除术后子宫内膜癌标准化发病比为0.56(95%CI 0.12-1.64),乳腺癌为0.86(95%CI 0.67-1.09)。
- 子宫内膜去除术组19.8%的女性接受了后续子宫切除术,风险约为对照组的四倍(调整HR 3.63)。
- 子宫肌瘤、年龄小于35岁、至少两次剖宫产史和绝育史与后续子宫切除术风险增加相关。
核心结论
- 在芬兰,子宫内膜去除术与子宫内膜癌或乳腺癌风险升高无关。
- 子宫肌瘤、年轻年龄以及既往剖宫产或绝育史与后续子宫切除术风险增加相关。
研究设计与样本
- 回顾性队列研究,从医院出院登记处提取芬兰1997-2014年间所有30-49岁接受子宫内膜去除术的女性记录,并与癌症登记处和芬兰中央人口登记处链接。
- 子宫内膜去除术队列共5,484名女性,随访39,892人年;对照组为从芬兰中央人口登记处提取的26,938名同龄女性。
主要发现
- 子宫内膜去除术队列共诊断154例癌症,标准化发病比(观察与预期比)为0.96(95%CI 0.82-1.13)。
- 子宫内膜癌标准化发病比为0.56(95%CI 0.12-1.64),乳腺癌为0.86(95%CI 0.67-1.09)。
- 1,086名(19.8%)女性接受了后续子宫切除术,子宫内膜去除术队列的子宫切除术风险约为对照组的四倍(调整HR 3.63,95%CI 3.32-3.96)。
- 易致后续子宫切除术的因素包括子宫肌瘤(调整HR 1.78,95%CI 1.03-3.10)、年龄小于35岁(调整HR 1.44,95%CI 1.15-1.81)、至少两次既往剖宫产(调整HR 1.27,95%CI 1.04-1.55)和绝育史(调整HR 1.15,95%CI 1.01-1.32)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To study the risk of endometrial cancer and breast cancer and the hysterectomy rate after endometrial ablation. METHODS: In this retrospective cohort study, records of all women with endometrial ablation at ages 30-49 years in Finland (1997-2014) were extracted from the Hospital Discharge Register and linked to the Cancer Registry and Finnish Central Population Register. The primary outcome was cancer incidences in the endometrial ablation cohort compared with those in the background population of the same age. Secondarily, the postablation hysterectomy rate was compared with that of a control cohort of similar-aged women extracted from the Finnish Central Population Register. Multivariate regression models with adjustment for age, parity, number of cesarean deliveries, history of sterilization, and the duration of follow-up were evaluated as risk factors for postablation hysterectomy. RESULTS: In total, 154 cancers (standardized incidence ratio [observed-to-expected ratio] 0.96, 95% CI 0.82-1.13) were diagnosed among 5,484 women treated with endometrial ablation during the follow-up of 39,892 women-years. The standardized incidence ratio for endometrial cancer was 0.56 (95% CI 0.12-1.64) and for breast cancer 0.86 (95% CI 0.67-1.09). A total of 1,086 (19.8%) women had postablation hysterectomy. Risk of hysterectomy was almost fourfold in the endometrial ablation cohort compared with 26,938 women in a control group (adjusted hazard ratio [HR] 3.63, 95% CI 3.32-3.96). Factors predisposing to postablation hysterectomy were leiomyomas (adjusted HR 1.78, 95% CI 1.03-3.10), age younger than 35 years (adjusted HR 1.44, 95% CI 1.15-1.81), at least two prior cesarean deliveries (adjusted HR 1.27, 95% CI 1.04-1.55), and history of sterilization (adjusted HR 1.15, 95% CI 1.01-1.32). CONCLUSION: Endometrial ablation was not associated with an elevated endometrial cancer or breast cancer risk in Finland. Leiomyomas, young age, and history of prior cesarean deliveries or sterilization were associated with an increased risk of postablation hysterectomy.
引用
- Soini T, Rantanen M, Paavonen J, et al. Long-term Follow-up After Endometrial Ablation in Finland: Cancer Risks and Later Hysterectomies. Obstet Gynecol. 2017. PMID: 28796675. doi:10.1097/AOG.0000000000002166
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。